Hannah Ledford is a Senior Medical Writer II at Exelixis, a position held since April 2021, previously serving as a Senior Medical Writer I. Prior experience includes working as a Regulatory Medical Writer at International Consulting Group, Inc. from September 2020 to March 2021, and as a Postdoctoral Researcher at Princeton University, where research focused on structural determination of cardiac membrane proteins using cryo-electron microscopy. Additionally, Hannah was a Graduate Student Researcher at the University of California, Davis, specializing in cardiac arrhythmias and channelopathies, particularly investigating the hERG potassium channel in relation to Long QT Syndrome. Educational qualifications include a Ph.D. in Molecular, Cellular, and Integrative Physiology from the University of California, Davis, and a Bachelor’s Degree in Pre-Medicine and English Literature from the University of Utah.